Ocumetics Technology Corp (TSE:OTC) has released an update.
Ocumetics Technology Corp. has started manufacturing innovative intraocular lenses for a pioneering human study in the Dominican Republic, marking a significant step in revolutionizing vision correction post-cataract surgery. The collaboration with Bioana will utilize advanced medical device expertise to ensure the quality and efficacy of the lenses. This development is critical for the company’s pursuit of regulatory approval and bringing the product to market.
For further insights into TSE:OTC stock, check out TipRanks’ Stock Analysis page.
